This article is maintained by: Elsevier
Article Title: Respuesta a: “Efectividad de alirocumab y evolocumab (PCSK9i) en el tratamiento de la hipercolesterolemia”
Journal Title: Medicina Clínica
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2025.107148
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2025.106924
Content Type: simple-article
Copyright: © 2025 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.